drugset / Trial / NCT05100160
Gabapentin for the Reduction of Opiate Use Following Pulmonary Resection (GROUP Trial)
Non-randomizedSingle-groupOpen-labelSupportive care
Summary
The aim of this study is to determine if the reduction in narcotic requirement following pulmonary resection with gabapentin is clinically significant when compared to the effect seen with placebo. We have defined clinically meaningful as a reduction by 30 Morphine equivalent doses (MED)
Timeline
- Start
- 2021-09-15
- Primary completion
- 2023-01-03
- Completion
- 2023-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gabapentin | Small molecule | — | Oral |